NIH-funded research R01 grant

Improving care for dementia patients by addressing social needs using AI

Official title: iSMART: intelligent Social risk Management in AD/ADRD paTients

Funded at University of Florida · NIH-11169926 · Data updated 2026-11-12

This study is working on a smart tool to help improve care for people with dementia, especially those from diverse backgrounds or facing financial challenges, by using technology to better understand and meet their unique needs.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startAugust 15, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$722,946
NIH project number5R01AG089445-02
Project IDNIH-11169926 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 65 and older living with Alzheimer's disease or related dementias, especially those from minority or disadvantaged backgrounds.

Less likely to help

Patients who do not have dementia or are younger than 65 years old may not benefit from this research.

What this research studies

This research focuses on enhancing the care of individuals living with dementia, particularly those from racial-ethnic minority groups and socioeconomically disadvantaged backgrounds. It aims to develop an intelligent platform called iSMART that utilizes artificial intelligence and real-world data to identify and address social determinants of health affecting these patients. By integrating this platform into electronic health records, the project seeks to improve the quality of care and overall quality of life for patients with Alzheimer's disease and related dementias. The approach involves analyzing large datasets to uncover unmet social needs and provide tailored support.

Why it matters

Potential benefit: If successful, this research could significantly improve the quality of care and life for dementia patients by addressing their social needs.

How similar studies have gone: Previous research has shown promise in using AI and social determinants of health to improve patient outcomes, indicating that this approach has potential for success.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Guo, Jingchuan — University of Florida
  • Study coordinator: Guo, Jingchuan

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.